XML 38 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Current assets    
Cash and equivalents $ 105 $ 349
Accounts receivable - trade, net 6,151 9,123
Other receivables 200 1,267
Inventory 1,568 1,788
Other 3,884 7,492
Derivative financial instruments 34,234 42,803
Total 46,142 62,822
Oil and natural gas properties, full cost method of accounting, net 118,897 124,068
Pipeline assets, net 58,069 59,088
Other property and equipment, net 15,673 14,726
Other, net 1,051 3,497
Equity investment 10,471 12,994
Derivative financial instruments 17,360 29,516
Total assets 267,663 306,711
Current liabilities    
Accounts payable 3,978 6,286
Revenue payable 3,529 4,972
Accrued expenses and other 5,571 8,700
Litigation reserve 4,415 3,081
Current portion of long-term debt 167,355 3,000
Derivative financial instruments 5,424 5,223
Total 190,272 31,262
Derivative financial instruments 2,999 4,611
Long-term debt   190,000
Asset retirement obligations 12,130 11,733
Other 348 4,559
Total liabilities 205,749 242,165
Commitments and contingencies      
Stockholders' equity    
Common stock, $0.01 par value; 40,000,000 authorized shares; 9,935,337 and 12,409,042 issued and outstanding, respectively 124 99
Additional paid-in capital 382,870 378,093
Accumulated deficit (381,545) (370,384)
Total equity 1,451 7,810
Total liabilities and equity 267,663 306,711
Series A Preferred Stock
   
Stockholders' equity    
Series A Cumulative Redeemable Preferred Stock, $0.01 par value; issued and outstanding - 6,000 shares 60,463 56,736
Series B Preferred Stock
   
Stockholders' equity    
Preferred stock, $0.01 par value; 5,000,000 authorized shares; 215,662 and 236,231 Series B Voting Preferred Stock issued and outstanding, respectively $ 2 $ 2